Kathleen Siler

Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.

Jeffrey Schlom, Diane Eggensperger, David Colcher et al. · PubMed · 1992 · 128 citations

Life Sciences, Immunology, Oncology +13

Advantage of Dose Fractionation in Monoclonal Antibody-Targeted Radioimmunotherapy

Jeffrey Schlom, Alfredo Molinolo, Jean F. Simpson et al. · JNCI Journal of the National Cancer Institute · 1990 · 109 citations

Medicine, Nuclear Medicine, Oncology +17

Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.

Jeffrey Schlom, Kathleen Siler, Diane E. Milenic et al. · PubMed · 1991 · 105 citations

Medicine, Oncology, Pharmacology +17

Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.

Chaitanya Divgi, Andrew M. Scott, L Dantis et al. · PubMed · 1995 · 77 citations

Medicine, Nuclear Medicine, Oncology +17

Diet‐induced alterations in the discoid shape and phospholipid fatty acid compositions of rat erythrocytes

G. Ananda Rao, Kathleen Siler, Edward C. Larkin · Lipids · 1979 · 39 citations

Life Sciences, Nutritional Sciences, Physiology +15